Explore the words cloud of the VOIC project. It provides you a very rough idea of what is the project "VOIC" about.
The following table provides information about the project.
NEURO DEVICE GROUP SPOLKA AKCYJNA
|Coordinator Country||Poland [PL]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-02-01 to 2019-07-31|
Take a look of project's partnership.
|1||NEURO DEVICE GROUP SPOLKA AKCYJNA||PL (WARSZAWA)||coordinator||50˙000.00|
Home therapy is the future of many available medical therapies. Home therapy does not require any additional medical staff support or hospital space, resulting in large savings for healthcare services. Aphasia therapy is one which could be potentially moved to the home setting, resulting in great benefits for patients. Aphasia is a kind of brain damage caused mainly by a stroke which prevents a person’s linguistic communication while maintaining the intellect intact. It is independent of age or sex, hence everyone is at risk - every year in EU there are almost 300 000 new cases. Most important for aphasia therapy is to start directly after it is diagnosed. Neuro Device Group with project VOIC aims at providing easy to use neuro-stimulation medical device coupled with software to provide the therapy at home setting. Currently, there is no dedicated device for aphasia therapy on the market, hence VOIC is a market-creating innovation. Our proposed therapy is more efficient and costs much less than the state-of-the-art standard speech therapy with a neuro-therapist. VOIC will be offered to patients such that the therapy starts quickly at a lower cost of a few thousand euros. We also want to offer VOIC to the therapists who can attend more patients at the same time, providing an additional source of income and patient satisfaction. The indirect benefit of the healthcare and retirement systems cannot be underestimated: lower cost of therapy and reduced cost of social benefits per patient, which can sum up to €3bn savings every year. The project will be well aligned with the company strategy and global trends in medical treatment. The market for medical devices is rapidly growing at 14% CAGR and is going to reach €13bn in 2023. The market demand has been initially confirmed with patients, medical universities, and big medical devices distributors.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VOIC" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "VOIC" are provided by the European Opendata Portal: CORDIS opendata.
Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any contRead More
Utilizing an innovative chemical platform to defeat antimicrobial resistanceRead More
IOT and cloud computing for online medical analysis service platformRead More